Does Adding Pembro Improve PFS in High-Risk Cervical Cancer?
Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.
MDedge News
source https://www.medscape.com/s/viewarticle/997608?src=rss
MDedge News
source https://www.medscape.com/s/viewarticle/997608?src=rss
Comments
Post a Comment